Epidemiological Prevalence Of Viral Hepatitis And HIV Infection Among Volunteer Blood Donors In Kinshasa
Abstract
Keywords
Full Text:
PDFReferences
AFSSAPS (French Agency for the Safety of Health Products). Recommendations for good practice: transfusion of fresh frozen plasma: products, indications, August 2002. Transfus Clin Biol 2002; 9: 333-356.
Balian, Perlemuter G, hepato-gastro-enterology. Masson, Paris, (2003) , 94-96. A perspective on long-term outcome. Semin Liver Dis 2000; 30: 1735
Acharki M. Benaissa A. study of the long-term response of patients with viral hepatitis C treated with dual therapy. Medicine thesis Rabat 2002, available in the library of the Faculty of Medicine and Pharmacy of Rabat.
Allain JP. Emerging viruses in blood transfusion. Vox Blood 2000; 78:243248.
Allain JP. Transfusion risks of yesterday and today. Transfus Clin Biol 2003; 10: 1-5
Assal Coste J, Barlet V, Laperche S, Cornillot C, Smilovici W, Pillonel J et al. Application of molecular biology to transfusion safety; viral genome screening. Transfus Clin Biol 2003; 10: 217-226
Aqodad N. The treatment of chronic viral hepatitis C: Experience of the hepato-gastroenterology department at the CHU Hassan II in Fez. Dissertation for obtaining the 2006 specialty diploma. Faculty of Medicine and Pharmacy of Fez.
Asselah T, Martinot M, Boyer N, Marcellin P. Genetic variability of hepatitis C virus: clinical implications. Focus. Gastroenterol Clin Biol 2000; 24: 175-184.
Ba et al. HIV infection in prison: prevalence and associated factors, Medicine and Infectious Diseases Volume 47, Issue 4, Supplement, June 2017, Pages S142-S143
Barbara J. Surrogate test. Vox Blood 2000; 78 (suppl 2):63-65
DOI: http://dx.doi.org/10.52155/ijpsat.v39.1.5381
Refbacks
- There are currently no refbacks.
Copyright (c) 2023 Lucie Mawasengo Kiezo

This work is licensed under a Creative Commons Attribution 4.0 International License.